Stocks
Cortexyme () ROA US GAAP (year values) |
|||||||||
| 2017 | 2018 | 2019 | 2020 | 2021 | LTM ? | CAGR 5 years ? | |||
| ROA, % | ? | -158.5% | -17.1% | -29.7% | -40.6% | -67.5% | -127.2% | ||
| Changes by years, y/y, % | +141pp | -13pp | -11pp | -27pp | -19.2% | ||||
Cortexyme. ROA, %
Cortexyme. ROA, changes, pp
Cortexyme () ROA US GAAP (quarter values) |
||||||||
| 2021Q2 | 2021Q3 | 2021Q4 | 2022Q1 | 2022Q2 | LTM ? | |||
| ROA, % | ? | -53.8% | -59.1% | -117.5% | -133.6% | -127.2% | -127.2% | |
| Changes by years, y/y, % | -28pp | -26pp | -77pp | -86pp | -73pp | |||
| Changes by quarters, q/q, % | -6pp | -5pp | -58pp | -16pp | +6pp | |||
